$3.00 Billion in Sales Expected for Mylan N.V. (MYL) This Quarter
Analysts expect Mylan N.V. (NASDAQ:MYL) to post sales of $3.00 billion for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Mylan N.V.’s earnings. The lowest sales estimate is $2.96 billion and the highest is $3.06 billion. Mylan N.V. reported sales of $2.56 billion during the same quarter last year, which would suggest a positive year over year growth rate of 17.2%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Wednesday, August 9th.
On average, analysts expect that Mylan N.V. will report full year sales of $3.00 billion for the current year, with estimates ranging from $12.29 billion to $12.61 billion. For the next financial year, analysts forecast that the firm will report sales of $13.09 billion per share, with estimates ranging from $12.92 billion to $13.30 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover Mylan N.V..
Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings data on Wednesday, May 10th. The company reported $0.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.92 by $0.01. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.81 billion. Mylan N.V. had a return on equity of 23.69% and a net margin of 4.59%. The company’s revenue was up 24.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 earnings per share.
A number of research analysts have commented on MYL shares. Royal Bank Of Canada decreased their price objective on Mylan N.V. from $39.00 to $36.00 and set a “sector perform” rating on the stock in a research report on Thursday, May 11th. ValuEngine lowered Mylan N.V. from a “buy” rating to a “hold” rating in a research report on Wednesday, June 14th. Wells Fargo & Company restated a “market perform” rating and issued a $40.00 price target on shares of Mylan N.V. in a research report on Wednesday, May 31st. BidaskClub upgraded Mylan N.V. from a “sell” rating to a “hold” rating in a research report on Thursday, June 22nd. Finally, Barclays PLC upgraded Mylan N.V. from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $47.00 to $50.00 in a research report on Monday, May 22nd. Two analysts have rated the stock with a sell rating, eleven have given a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Mylan N.V. currently has a consensus rating of “Buy” and a consensus price target of $50.21.
Shares of Mylan N.V. (NASDAQ:MYL) opened at 32.00 on Tuesday. The stock has a 50 day moving average price of $38.42 and a 200 day moving average price of $39.28. Mylan N.V. has a one year low of $31.47 and a one year high of $50.40. The firm has a market cap of $17.15 billion, a price-to-earnings ratio of 31.97 and a beta of 1.27.
In related news, President Rajiv Malik sold 25,000 shares of Mylan N.V. stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the completion of the transaction, the president now owns 799,855 shares in the company, valued at $31,994,200. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Anthony Mauro sold 10,000 shares of Mylan N.V. stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the transaction, the insider now owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.
A number of institutional investors have recently bought and sold shares of MYL. First Personal Financial Services boosted its position in Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock worth $107,000 after buying an additional 681 shares during the last quarter. Global X Management Co. LLC boosted its position in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock worth $118,000 after buying an additional 1,441 shares during the last quarter. Ropes Wealth Advisors LLC acquired a new position in Mylan N.V. during the first quarter worth approximately $136,000. Oakworth Capital Inc. boosted its position in Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock worth $166,000 after buying an additional 1,000 shares during the last quarter. Finally, State of Alaska Department of Revenue acquired a new position in Mylan N.V. during the first quarter worth approximately $188,000. Institutional investors and hedge funds own 70.19% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/08/08/3-00-billion-in-sales-expected-for-mylan-n-v-myl-this-quarter.html.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.